(Q34650071)

3 August 2017

Silymarin in non alcoholic fatty liver disease (English)

1 reference

3 August 2017

alcoholic fatty liver

1 reference

metabolic dysfunction–associated steatotic liver disease

inferred from title

1 reference

Fulvio Cacciapuoti

1

1 reference

3 August 2017

Anna Scognamiglio

2

1 reference

3 August 2017

Rossella Palumbo

3

1 reference

3 August 2017

Raffaele Forte

4

1 reference

3 August 2017

Federico Cacciapuoti

5

1 reference

3 August 2017

1 March 2013

1 reference

World Journal of Hepatology

3 August 2017

1 reference

3 August 2017

5

1 reference

3 August 2017

109-113

1 reference

3 August 2017

3

1 reference

Nonalcoholic fatty liver disease (NAFLD) in nonobese patients with diabetes: Prevalence and relationships with hemodynamic alterations detected with Doppler sonography().

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612568

Standardized ultrasound hepatic/renal ratio and hepatic attenuation rate to quantify liver fat content: an improvement method

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612568

Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612568

Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612568

Global challenges in liver disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612568

A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612568

The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612568

Body fat distribution, liver enzymes, and risk of hypertension: evidence from the Western New York Study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612568

Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612568

Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612568

Milk thistle for the treatment of liver disease: a systematic review and meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612568

AGA technical review on nonalcoholic fatty liver disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612568

Nonalcoholic fatty liver disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612568

Silymarin: a review of its clinical properties in the management of hepatic disorders

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612568

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612568

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612568

Milk thistle (Silybum marianum) for the therapy of liver disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612568

Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612568

Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612568

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612568

Comparison of the histological lesions in tissue specimens taken from the right and left lobe of the liver in alcoholic liver disease (author's transl)

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612568

In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases

7 July 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V5.I3.109

Non-alcoholic steatohepatitis in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V5.I3.109

Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V5.I3.109

Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V5.I3.109

Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V5.I3.109

Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V5.I3.109

Association of nonalcoholic fatty liver disease with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V5.I3.109

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V5.I3.109

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V5.I3.109

Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V5.I3.109

Nonalcoholic steatohepatitis: an expanded clinical entity.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612568

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

26 October 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V5.I3.109

The effect of a silybin-vitamin e-phospholipid complex on nonalcoholic fatty liver disease: a pilot study

21 January 2018

1 reference

12 December 2020

Nonalcoholic fatty liver disease

1 reference

12 December 2020

One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation

1 reference

12 December 2020

Association between microsomal triglyceride transfer protein gene polymorphism and the biological features of liver steatosis in patients with type II diabetes

1 reference

12 December 2020

Liver echogenicity: measurement or visual grading?

1 reference

12 December 2020

The relationship between serum transaminase activities and fatty liver in children with simple obesity

1 reference

12 December 2020

Sonographic diagnosis of fatty liver using a histogram technique that compares liver and renal cortical echo amplitudes

1 reference

12 December 2020

The efficacy of licorice root extract in decreasing transaminase activities in non-alcoholic fatty liver disease: a randomized controlled clinical trial

1 reference

12 December 2020

Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study

1 reference

12 December 2020

Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis

1 reference

12 December 2020

Identifiers

DOI

10.4254/WJH.V5.I3.109

1 reference

3 August 2017

1 reference

3 August 2017

1 reference